春和景明，我们于3月21日在阿斯利康北京、上海办公室及线上迎来了CQAF 2024第一季度的会议。此次会议是CQAF首次围绕GCP/GVP/GCLP的NMPA核查动态展开讨论，并分享相关案例。同时，作为CQAF首次推出的质量求新板块，我们从细胞治疗临床供应链的流程和风险管理出发，探讨创新领域的质量管理的策略和实践。此次会议约有30多名会员积极参加了线下研讨，170名CQAF会员从线上拨入。对于来自四面八方的同仁，这既是一个以行业内热点，痛点为出发点延伸至根本的学习交流的机会，更是一场许久未遇的老朋友们间的欢聚。 ...

在明媚的阳光中，迎来2024年第一期Regulatory Express, 想和您分享以下话题，欢迎点击正文链接，查看详情。 ...

The CQAF 2023 Q4 meeting, was held online on 22nd December. This is the first time to discuss the medical device (MD) regulation, audit, inspection and relevant safety reporting in the quarterly meeting. Around 130 CQAF members joined the meeting. Based on the pre-survey results by members, Ms. Athena Luo from Abbvie and Ms. Conny Mo from Pving shared their understanding and insights to the relevant regulation and safety reporting. At last, Sally Zhang along with CQAF Core Team and Advisory Group summarized the CQAF achievements of 2023, recent updates and the prospects of 2024. ...

在明媚的阳光中，迎来2023年第四期Regulatory Express, 想和您分享以下话题，欢迎点击正文链接，查看详情。 ...

The CQAF 2023 Q3 meeting, was held in the Shanghai office of BI and the Beijing office of Bayer on 21st September, as well as open online to members. More than 170 CQAF members joined the meeting online and around 30 members had interaction and discussion with the core team on site. The conference started with the announcement of CQAF organization updates and key progress. Then Sean Xu, Amy Jiang, and Dr. Yifeng Shen walked the audience through the “Overview of CAPA process and relevant cases discussion”, based on the pre-survey results and real cases provided by the members. ...

感谢你们在过去13年与中国质量保证论坛（CQAF）一路同行，中国质量保证论坛作为中国领先的医药行业质量专业人士的交流平台，在创始人，历任主席，核心团队，行业领袖的领导下，在会员们，相关行业协会和平台的支持以及多元合作的推动之下，我们的组织在支持和贡献行业健康发展为己任的道路上持续提升和优化，今天，秋风送爽，丹桂飘香，我们也迎来了新一届任期（2023-2025）的核心团队，我们非常高兴地宣布： ...